- Sanofi (EPA:SAN) Publishes 2013 Corporate Social Responsibility (CSR) Report - Sanofi (EPA:SAN) Publishes 2013 Corporate Social Responsibility (CSR) Report

The report offers a close look at the compant's Corporate Social Responsibility priorities and practices
Wednesday, June 11, 2014 - 4:40am

CAMPAIGN: ReportAlerts from 2014

CONTENT: Press Release

June 11, 2014 /3BL Media/ - As a leading healthcare company, Sanofi's mission is to protect the health, improve the quality of life and provide hope and respond to the potential healthcare needs of 7 billion people around the world.

You will find the CSR report and the associated CSR tools below :

  • Sanofi 2013 CSR report offers a close look at Sanofi’s Corporate Social Responsibility (CSR) priorities and practices. For each of the four CSR pillars (Patient, Ethics, People, and Planet), it describes the challenges, the strategic approaches and the progress toward meeting the goals. Read the Report here
  • "Our Responsibility” in
    Learn more about the Group’s key positions and achievements here.
  • The CSR Download Center
    Find detailed information on CSR Factsheets, Policies, Codes, Brochures, etc. Visit the Download Center here.
  • “At the heart of CSR” video
    This 3-minute video gives an overview of our main commitments here.
  • The 2014-2015 CSR Brochure
    Intended for the general public, the 8 page brochure gives an overview of our 4-pillar strategy here.
  • The Chapter 4 of the Document de Référence
    To meet the Grenelle 2 French law requirements, a dedicated CSR chapter was included in the Sanofi Financial Report “Document de Référence”. Read the English translation in the here.
  • The Diversity and inclusion Report
    A new comprehensive report was issued in April 2014. Read the Report in the Download Center.

You can find more information about Sanofi CSR initiatives and positions at or in the Download Center

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY)

For any further information, please contact